Search clinical trials for: Ibrutinib 420 mg
Total 17545 results
-
Johnson & Johnson Private LimitedCompletedLymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-CellIndia
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Autoimmune Hemolytic Anemia | Monoclonal B-Cell Lymphocytosis CLL-TypeItaly
-
US Oncology ResearchAbbVie; Pharmacyclics LLC.Active, not recruitingBreast Neoplasms | Malignant Neoplasm of BreastUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorUnited States
-
Oncternal Therapeutics, IncUniversity of California, San Diego; Pharmacyclics LLC.; California Institute...Active, not recruitingMantle Cell Lymphoma | Marginal Zone Lymphoma | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
UCB CelltechParexel; Comac Medical; MAC Clinical Research; ARENSIA, MoldovaCompletedPsoriatic ArthritisBulgaria, Moldova, Republic of, United Kingdom
-
Boehringer IngelheimCompleted
-
PfizerCompleted
-
Oregon Health and Science UniversityNational Center for Advancing Translational Sciences (NCATS)Not yet recruiting
-
Christian BuskeAmgen; Janssen, LPRecruitingWaldenstrom MacroglobulinemiaAustria, Germany, Greece
-
Vifor (International) Inc.FortreaCompletedSickle Cell DiseaseUnited States, France, Greece, Lebanon, United Kingdom
-
PETHEMA FoundationActive, not recruitingChronic Lymphocytic LeukemiaSpain
-
TG Therapeutics, Inc.CompletedMantle Cell Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
Merck Sharp & Dohme LLCCompletedHypertension | Isolated Systolic Hypertension (ISH)
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Michael ChoiPharmacyclics LLC.Withdrawn
-
CelgeneCompleted
-
UCB Japan Co. Ltd.CompletedRheumatoid ArthritisJapan, Korea, Republic of, Taiwan
-
The Lymphoma Academic Research OrganisationJanssen Pharmaceutica N.V., BelgiumTerminatedB-cell LymphomaFrance, Belgium
-
The Lymphoma Academic Research OrganisationInstitute of Cancer Research, United KingdomRecruitingMantle Cell LymphomaFrance, United Kingdom, Belgium
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...RecruitingAcute MalariaBurkina Faso, Gabon, Mozambique, Uganda
-
Pharmacyclics Switzerland GmbHJanssen Biotech, Inc., including Johnson & JohnsonEnrolling by invitationLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Solid Tumor | Leukemia, B-cell | Graft Vs Host DiseaseUnited States, Spain, Taiwan, United Kingdom, Australia, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, France, Turkey, Czechia, Hungary, Poland, Sweden
-
Janssen-Cilag Ltd.CompletedLymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-CellFrance
-
The Lymphoma Academic Research OrganisationCompletedIntraocular Lymphoma | Primary Central Nervous LymphomaFrance
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Lymphocytic LeukemiaItaly
-
Janssen-Cilag S.p.A.CompletedLeukemia, Lymphocytic, Chronic, B-CellItaly
-
The First Affiliated Hospital with Nanjing Medical...Xian-Janssen Pharmaceutical Ltd.UnknownChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina
-
Kirby InstituteRecruitingHepatitis C | Liver Cirrhoses | Liver InflammationAustralia
-
AdvanceCor GmbHCompletedStroke | Atherosclerosis | Carotid Stenosis | TIA | Transient-ischaemic Attack | Amaurosis FugaxGermany, United Kingdom
-
Dr. Reddy's Laboratories LimitedXenoPort, Inc.Completed
-
Boehringer IngelheimCompleted
-
Janssen-Cilag International NVCompleted
-
IRCCS San RaffaeleRecruiting
-
Memorial Sloan Kettering Cancer CenterOhio State University; Pharmacyclics LLC.; Janssen Biotech, Inc.CompletedT-cell Lymphoma | Relapsed and Refractory T-cell LymphomaUnited States
-
University of CologneCompletedNodular Lymphocyte-Predominant Hodgkin's LymphomaGermany
-
Memorial Sloan Kettering Cancer CenterFox Chase Cancer Center; Pharmacyclics LLC.TerminatedFollicular Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma, Grade 2 | Follicular Lymphoma Grade IIIaUnited States
-
Janssen Biotech, Inc.Pharmacyclics LLC.Approved for marketingRelapsed or Refractory Mantle Cell LymphomaUnited States, Brazil, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingRefractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL)United States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLC; Novartis PharmaceuticalsCompletedLymphoma | Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
University of Michigan Rogel Cancer CenterWithdrawnChronic Lymphocytic Leukemia | Lymphoma, Small LymphocyticUnited States
-
Janssen Research & Development, LLCCompleted
-
ShireCompleted
-
The University of Hong KongJanssen, LPUnknownFollicular Lymphoma | Chronic Hepatitis B | Chronic Lymphocytic Leukemia | Mantle-Cell Lymphoma | Lymphoma, Small Lymphocytic | Indolent B-cell Lymphomas | Waldenstrom's MacroglobulinaemiaHong Kong
-
Janssen Research & Development, LLCWithdrawnLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell
-
Bnai Zion Medical CenterTel-Aviv Sourasky Medical CenterRecruiting
-
Novartis PharmaceuticalsRecruitingFood AllergyUnited States, Spain, France, Germany, Italy, Netherlands, Canada, Japan, Australia
-
Peking University People's HospitalBeijing HospitalUnknownLeukemia, Lymphocytic, Chronic, B-Cell
-
Jeanette LundinRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaSweden, Norway